This project aims to develop ‘weaponised’ anti-Env antibodies and identify NK cell subpopulations which can effectively target and eliminate HIV-infected cells, including macrophages.
2022 - Ongoing
- Identifying anti-HIV envelope antibodies able to recognise HIV-infected cells and enhance their ability to mediate ADCC.
- Exploring subpopulations of NK cells which show potent cytotoxicity against HIV-infected targets.
- Developing immunotherapy-based strategies to expand populations of potent NK cells which can be used to eliminate HIV-infected cells in people with HIV.
In this project we are developing an immunotherapy-based strategy to enhance the elimination of HIV-infected cells as part of a combined HIV cure intervention. This is important to advance the possibility of a HIV cure for the millions of people living with HIV worldwide.
Partners +
Collaborators
- NHMRC
- American Foundation for AIDS Research (amfAR)
Project
Team
Meet the project team. Together, we are translating research into better health, for all.